Effect of Administration of Licensed TIV Vaccine on the Safety and Immunogenicity of an Unadjuvanted Sanofi Pasteur H1N1 Influenza Vaccine in Healthy Adult and Elderly Populations.

Trial Profile

Effect of Administration of Licensed TIV Vaccine on the Safety and Immunogenicity of an Unadjuvanted Sanofi Pasteur H1N1 Influenza Vaccine in Healthy Adult and Elderly Populations.

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Jul 2012

At a glance

  • Drugs Influenza A virus vaccine-H1N1; Influenza virus vaccine
  • Indications Influenza A virus H1N1 subtype; Influenza virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 31 Jul 2012 Actual end date changed from May 2010 to Apr 2010 as reported by ClinicalTrials.gov.
    • 27 Jan 2012 Actual end date changed from Apr 2010 to May 2010 as reported by ClinicalTrials.gov.
    • 04 Nov 2011 Additional trial identifier N01AI80003C identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top